Treatment with Propylthiouracil is Associated with Appearance of Antineutrophil Cytoplasmic Antibodies in Some Patients with Graves' Disease
Authors:
- Kiyoto AshizawaKAKiyoto Ashizawa
- Takao AndoTATakao Ando
- Yasuyo AbeYAYasuyo Abe
- Akane IdeAIAkane Ide
- Toshiro UsaTUToshiro Usa
- Tan TominagaTTTan Tominaga
- Eri EjimaEEEri Ejima
- Naokata YokoyamaNYNaokata Yokoyama
- Katsumi EguchiKEKatsumi Eguchi
- 1 July 2000
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 10 (7) , 595-599
Abstract
The use of propylthiouracil (PTU) for the treatment of Graves' disease is associated with few adverse effects such as skin eruptions, liver dysfunction, and agranulocytosis. Furthermore, recent studies described the development of antineutrophil cytoplasmic antibody (ANCA)-related glomerulonephritis and vasculitis in patients treated with PTU. Here we investigated whether PTU therapy per se is associated with the appearance of ANCA in patients with Graves' disease. We analyzed 119 serum samples from 117 patients with Graves' disease treated with either PTU (n = 56), or methimazole (MMI) (n = 21), as well as untreated patients (n = 42). Myeloperoxidase (MPO)-ANCA and proteinase 3 (PR3)-ANCA were tested by enzyme-linked immunosorbent assay (ELISA) kits. MPO-ANCA was negative in all patients treated with MMI therapy and untreated patients. However, MPO-ANCA was detected in 21 (37.5%) of 56 patients treated with PTU therapy. Furthermore, two patients who were negative for MPO-ANCA became positive after PTU therapy. The proportion of patients positive for MPO-ANCA increased with the prolongation of PTU therapy, but did not correlate with age, gender, and positive antithyroperoxidase (TPO) antibody. Among 21 MPO-ANCA positive patients, 12 had no symptoms, but 9 patients complained of myalgia, arthralgia, or common cold like symptoms after the appearance of MPO-ANCA. Three patients developed agranulocytosis or granulocytopenia, but none showed abnormal urinary findings. Our results suggest that PTU per se is associated with the production of MPO-ANCA in patients with Graves' disease.Keywords
This publication has 15 references indexed in Scilit:
- Case of propylthiouracil-induced ANCA associated small vessel vasculitisNephrology Dialysis Transplantation, 1998
- Small-Vessel VasculitisNew England Journal of Medicine, 1997
- Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: Report of three adult casesAmerican Journal of Kidney Diseases, 1995
- Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in childrenThe Journal of Pediatrics, 1994
- Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapyThe Lancet, 1993
- Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with wegener's granulomatosisArthritis & Rheumatism, 1993
- Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.Journal of Experimental Medicine, 1990
- Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.Journal of Clinical Investigation, 1989
- AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSISThe Lancet, 1985
- Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?BMJ, 1982